Murray, Frank & Sailer LLP is investigating a class action lawsuit on behalf who purchased or otherwise acquired securities of MedQuist, Inc. (Other OTC: MEDQ.PK); ("MedQuist" or the "Company") between April 23, 2002 and November 2, 2004, inclusive (the "Class Period").

Join the Case

Murray, Frank & Sailer LLP has learned that MedQuist issued materially false and/or misleading public statements. On November 2, 2004, Medquist announced that on October 29, 2004, the Company's Board concluded that the previously released financial statements from 2002 and 2003, as well all earnings releases and communications, should not be relied upon by investors. The Company’s statements followed the analysis of Debevoise & Plimpton LLP and PricewaterhouseCoopers LLP, who found that the way Medquist billed for services created ambiguities in the way client accounts were calculated, which led to incorrect billing of clients and incorrect accounting by the Company.

The deadline to join this potential action with Murray, Frank & Sailer LLP is January 7, 2005. If you would like information, please contact Eric J. Belfi at 1-800-497-8076 or at  [email protected].